Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.42 |
| ▸ | ITGAV | P06756 | 1/20 | 0.42 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.42 |
| ▸ | PROKR1 | Q8TCW9 | 3/20 | 0.42 |
| ▸ | BTK | Q06187 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8501348 | 0.90 | ITGB3 (0.48) | ITGB3ITGAVITGA2BPROKR1BTK | |
| SCHEMBL8474796 | 0.90 | ITGB3 (0.44) | ITGB3ITGAVITGA2BPROKR1BTK | |
| SCHEMBL14224072 | 0.87 | ITGB3 (0.43) | ITGB3ITGAVITGA2BPROKR1BTK | |
| SCHEMBL14195948 | 0.76 | ITGB3 (0.42) | ITGB3ITGAVITGA2BALDH1A1DPP4 | |
| SCHEMBL14195947 | 0.76 | ITGB3 (0.42) | ITGB3ITGAVITGA2BALDH1A1DPP4 | |
| SCHEMBL8487183 | 0.76 | ITGB3 (0.42) | ITGB3ITGAVITGA2BALDH1A1DPP4 | |
| SCHEMBL4720020 | 0.72 | ITGB3 (0.46) | ITGB3ITGAVITGA2BMAPK1DPP4 | |
| SCHEMBL11919539 | 0.71 | POLB (0.49) | ALDH1A1KDM4EPOLBMEN1KMT2A | |
| SCHEMBL13344630 | 0.70 | ITGB3 (0.54) | ITGB3ITGAVITGA2BALDH1A1MAPK1 | |
| SCHEMBL5856769 | 0.70 | ALDH1A1 (0.57) | ITGB3ITGAVITGA2BALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1506779-A1 | (3-(4-(Pyridin-2-ylamino)-butyryl)-2,3,4,4a,9,9a-hexahydro-1H-3-aza-fluoren-9-yl)-acetic acid derivatives and related tricyclic indanyls as alphaVbeta3 and alphaVbeta5 integrin inhibitors for the treatment of cancer and unstable angina | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-02-16 | — | — | EP | disclosed |